Bridgebio Oncology Therapeutics, Inc. (BBOT)

8.60 -0.31 (-3.48%) USD  |  NASDAQ  |  Apr 07, 10:18
More

Bridgebio Oncology Therapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
EyePoint Plc Upgrade
Praxis Precision Medicines, Inc. Upgrade
Rapport Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
Arcellx, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade